🚀 Apply for £10k+ grants with our Startup Launch Kit
shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)

    RFA-TS-25-036

    Centers for Disease Control and Prevention - ERA

    Opening date 1 Aug 2024, 12:00AM

    Closing date 4 Nov 2024, 12:00AM

    Funding Opportunity Number: RFA-TS-25-036

    Opportunity Category: Discretionary

    Expected Number of Awards: 8

    CFDA Number(s): 93.061 -- Innovations in Applied Public Health Research

    Cost Sharing or Matching Requirement: No

    Posted Date: Aug 01, 2024 12:00:00 AM EDT

    Closing Date: Nov 04, 2024 12:00:00 AM EST

    Closing Date Details: Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.

    Estimated Total Program Funding: 7500000

    Award Ceiling: $500000

    Eligible Applicants: Private institutions of higher education,Others (see text field entitled "Additional Information on Eligibility" for clarification),Native American tribal organizations (other than Federally recognized tribal governments),County governments,Native American tribal governments (Federally recognized),State governments,Public housing authorities/Indian housing authorities,Independent school districts,Public and State controlled institutions of higher education,Special district governments,Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility",City or township governments,Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education,Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

    Additional Information on Eligibility: See Section III. Eligibility Information.

    Agency Name: Centers for Disease Control and Prevention - ERA

    Description: The Centers for Disease Control/Agency for Toxic Substances and Disease Registry (CDC/ATSDR) is seeking investigator-initiated research that will identify and evaluate potential risk factors contributing to Amyotrophic Lateral Sclerosis (ALS), with preferred focus on research proposals that will examine factors related to military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents. Research proposals on preferred topics can be funded under one of three funding options, Funding Option A, Funding Option B, or Funding Option C. Funding Option A is intended to support ALS risk factor research investigations that have an existing, well substantiated evidence base and would benefit from strengthened rigorous evaluation. Funding Option B is intended to support novel ALS risk factor research investigations that may or may not have an existing evidence base, may be supported by limited and insufficient preliminary research, and are exploratory and developmental in nature. Funding Option C is intended to support research and better understanding of ALS risk including prevalence and incidence in communities such as racial and ethnic minority populations (e.g., Black or African American persons, Hispanic or Latino persons, Asian persons) and military veterans.

    Grantor Contact Information: Candis M. Hunter, PhD, MSPH, REHS ncipc_erpo@cdc.gov

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept